All Issue

2023 Vol.53, Issue 1 Preview Page

Original Article

30 June 2023. pp. 51-60
Liao DH, Zhao JB, Gregersen H. Gastrointestinal tract modelling in health and disease. World J Gastroenterol 2009;15:169-76. 10.3748/wjg.15.16919132766PMC2653308
Julio-Pieper M, López-Aguilera A, Eyzaguirre-Velásquez J, Olavarría-Ramírez L, Ibacache-Quiroga C, Bravo JA, et al. Gut Susceptibility to Viral Invasion: Contributing Roles of Diet, Microbiota and Enteric Nervous System to Mucosal Barrier Preservation. Int J Mol Sci 2021;22:4734. 10.3390/ijms2209473433946994PMC8125429
Belkaid Y, Hand TW. Role of the Microbiota in Immunity and Inflammation. Cell 2014;157:121-41. 10.1016/j.cell.2014.03.01124679531PMC4056765
Kim J, Koo BK, Yoon KJ. Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology. Viruses 2019;11:124. 10.3390/v1102012430704043PMC6409779
Liu L. Fields Virology, 6th Edition. Clinical Infectious Diseases 2014;59:613. 10.1093/cid/ciu346
Rouse BT, Mueller SN. Host Defenses to Viruses. Clinical Immunology 2019:365-74. 10.1016/B978-0-7020-6896-6.00025-9PMC7149641
Kim J, Koo BK, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol 2020;21:571-84. 10.1038/s41580-020-0259-332636524PMC7339799
Clevers H. Modeling Development and Disease with Organoids. Cell 2016;165:1586-97. 10.1016/j.cell.2016.05.08227315476
Rotavirus vaccines WHO position paper: January 2013 - Recommendations. Vaccine 2013;31:6170-1. 10.1016/j.vaccine.2013.05.03723746456
Lee LY, Ison MG. Diarrhea caused by viruses in transplant recipients. Transpl Infect Dis 2014;16:347-58. 10.1111/tid.1221224750282
Groome MJ, Moon SS, Velasquez D, Jones S, Koen A, van Niekerk N, et al. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ 2014;92:238-45. 10.2471/BLT.13.12806624700991PMC3967577
Knipping K, Garssen J, van't Land B. An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts. Virol J 2012;9:137. 10.1186/1743-422X-9-13722834653PMC3439294
Saxena K, Blutt SE, Ettayebi K, Zeng XL, Broughman JR, Crawford SE, et al. Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology. J Virol 2015;90:43-56. 10.1128/JVI.01930-1526446608PMC4702582
Yin Y, Bijvelds M, Dang W, Xu L, van der Eijk AA, Knipping K, et al. Modeling rotavirus infection and antiviral therapy using primary intestinal organoids. Antiviral Res 2015;123:120-31. 10.1016/j.antiviral.2015.09.01026408355
Wang W, Yin Y, Xu L, Su J, Huang F, Wang Y, et al. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections. Sci Signal 2017;10:eaah4248. 10.1126/scisignal.aah424828442624
Pervolaraki K, Stanifer ML, Münchau S, Renn LA, Albrecht D, Kurzhals S, et al. Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut. Front Immunol 2017;8:459. 10.3389/fimmu.2017.0045928484457PMC5399069
Hakim MS, Chen S, Ding S, Yin Y, Ikram A, Ma XX, et al. Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids. Sci Rep 2018;8:8341. 10.1038/s41598-018-26784-929844362PMC5974418
Yin Y, Dang W, Zhou X, Xu L, Wang W, Cao W, et al. PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target. Virulence 2018;9:83-98. 10.1080/21505594.2017.132644328475412PMC5955461
Yin Y, Chen S, Hakim MS, Wang W, Xu L, Dang W, et al. 6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling. Antiviral Res 2018;156:92-101. 10.1016/j.antiviral.2018.06.01129920300PMC7113846
Belliot G, Lopman BA, Ambert-Balay K, Pothier P. The burden of norovirus gastroenteritis: an important foodborne and healthcare-related infection. Clin Microbiol Infect 2014;20:724-30. 10.1111/1469-0691.1272224943671PMC7962369
Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U, Tenge VR, et al. Replication of human noroviruses in stem cell-derived human enteroids. Science 2016;353:1387-93. 10.1126/science.aaf521127562956PMC5305121
Hosmillo M, Chaudhry Y, Nayak K, Sorgeloos F, Koo BK, Merenda A, et al. Norovirus Replication in Human Intestinal Epithelial Cells Is Restricted by the Interferon-Induced JAK/STAT Signaling Pathway and RNA Polymerase II-Mediated Transcriptional Responses. mBio 2020;11:e00215-20. 10.1128/mBio.00215-2032184238PMC7078467
Lulla V, Dinan AM, Hosmillo M, Chaudhry Y, Sherry L, Irigoyen N, et al. An upstream protein-coding region in enteroviruses modulates virus infection in gut epithelial cells. Nat Microbiol 2019;4:280-92. 10.1038/s41564-018-0297-130478287PMC6443042
Tsang JO, Zhou J, Zhao X, Li C, Zou Z, Yin F, et al. Development of Three-Dimensional Human Intestinal Organoids as a Physiologically Relevant Model for Characterizing the Viral Replication Kinetics and Antiviral Susceptibility of Enteroviruses. Biomedicines 2021;9:88. 10.3390/biomedicines901008833477611PMC7831294
V'kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 2021;19:155-70. 10.1038/s41579-020-00468-633116300PMC7592455
Adney DR, van Doremalen N, Brown VR, Bushmaker T, Scott D, de Wit E, et al. Replication and Shedding of MERS-CoV in Upper Respiratory Tract of Inoculated Dromedary Camels. Emerg Infect Dis 2014;20:1999-2005. 10.3201/eid2012.14128025418529PMC4257817
Breban R, Riou J, Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 2013;382:694-9. 10.1016/S0140-6736(13)61492-023831141
Chowell G, Blumberg S, Simonsen L, Miller MA, Viboud C. Synthesizing data and models for the spread of MERS-CoV, 2013: Key role of index cases and hospital transmission. Epidemics 2014;9:40-51. 10.1016/j.epidem.2014.09.01125480133PMC4258236
Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013;495:251-4. 10.1038/nature1200523486063PMC7095326
Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013;13:752-61. 10.1016/S1473-3099(13)70204-423891402
Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease. Clin Microbiol Rev 2015;28:465-522. 10.1128/CMR.00102-1425810418PMC4402954
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020;181:271-280.e8. 10.1016/j.cell.2020.02.05232142651PMC7102627
Bestle D, Heindl MR, Limburg H, van Lam van T, Pilgram O, Moulton H, et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci Alliance 2020;3:e202000786. 10.26508/lsa.20200078632703818PMC7383062
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. 10.1038/s41591-020-0968-332651579
Prasad A, Prasad M. Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading? Front Med (Lausanne) 2020;7:370. 10.3389/fmed.2020.0037032850890PMC7419463
Giobbe GG, Bonfante F, Jones BC, Gagliano O, Luni C, Zambaiti E, et al. SARS-CoV-2 infection and replication in human gastric organoids. Nat Commun 2021;12:6610. 10.1038/s41467-021-26762-234785679PMC8595698
Zhou J, Li C, Zhao G, Chu H, Wang D, Yan HH, et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci Adv 2017;3:eaao4966. 10.1126/sciadv.aao496629152574PMC5687858
Beumer J, Geurts MH, Lamers MM, Puschhof J, Zhang J, van der Vaart J, et al. A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses. Nat Commun 2021;12:5498. 10.1038/s41467-021-25729-734535662PMC8448725
Triana S, Metz‐Zumaran C, Ramirez C, Kee C, Doldan P, Shahraz M, et al. Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut. Mol Syst Biol 2021;17:e10232. 10.15252/msb.20211023233904651PMC8077299
Heuberger J, Trimpert J, Vladimirova D, Goosmann C, Lin M, Schmuck R, et al. Epithelial response to IFN‐γ promotes SARS‐CoV‐2 infection. EMBO Mol Med 2021;13:e13191. 10.15252/emmm.20201319133544398PMC7995094
Yamashita F, Shibuya S, Townley RR, Davidson GP, Bishop RF, Holmes IH, et al. DUOVIRUS IN PSEUDOCHOLERA INFANTUM. The Lancet 1975;1::1297. 10.1016/S0140-6736(75)92582-948924
Vu DL, Cordey S, Brito F, Kaiser L. Novel human astroviruses: Novel human diseases? J Clin Virol 2016;82:56-63. 10.1016/j.jcv.2016.07.00427434149
Kriston S, Willcocks MM, Carter MJ, Cubitt WD. Seroprevalence of astrovirus types 1 and 6 in London, determined using recombinant virus antigen. Epidemiol Infect 1996;117:159-64. 10.1017/S09502688000012668760964PMC2271669
Koopmans MP, Bijen MH, Monroe SS, Vinjé J. Age-Stratified Seroprevalence of Neutralizing Antibodies to Astrovirus Types 1 to 7 in Humans in The Netherlands. Clin Diagn Lab Immunol 1998;5:33-7. 10.1128/CDLI.5.1.33-37.19989455876PMC121387
Mitchell DK, Matson DO, Cubitt WD, Jackson LJ, Willcocks MM, Pickering LK, et al. Prevalence of antibodies to astrovirus types 1 and 3 in children and adolescents in Norfolk, Virginia. Pediatr Infect Dis J 1999;18:249-54. 10.1097/00006454-199903000-0000810093946
Triana S, Stanifer ML, Metz‐Zumaran C, Shahraz M, Mukenhirn M, Kee C, et al. Single‐cell transcriptomics reveals immune response of intestinal cell types to viral infection. Mol Syst Biol 2021;17:e9833. 10.15252/msb.2020983334309190PMC8311733
To KK, Chan JF, Chen H, Li L, Yuen KY. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis 2013;13:809-21. 10.1016/S1473-3099(13)70167-123969217
Klenk HD. Influenza Viruses En Route from Birds to Man. Cell Host Microbe 2014 ;15:653-4. 10.1016/j.chom.2014.05.01924922565
Huang L, Hou Q, Ye L, Yang Q, Yu Q. Crosstalk between H9N2 avian influenza virus and crypt-derived intestinal organoids. Vet Res 2017;48:71. 10.1186/s13567-017-0478-629096712PMC5667514
Danthi P, Holm GH, Stehle T, Dermody TS. Reovirus Receptors, Cell Entry, and Proapoptotic Signaling. Adv Exp Med Biol 2013;790:42-71. 10.1007/978-1-4614-7651-1_323884585PMC4724410
Müller L, Berkeley R, Barr T, Ilett E, Errington-Mais F. Past, Present and Future of Oncolytic Reovirus. Cancers (Basel) 2020;12:3219. 10.3390/cancers1211321933142841PMC7693452
Tarris G, de Rougemont A, Charkaoui M, Michiels C, Martin L, Belliot G. Enteric Viruses and Inflammatory Bowel Disease. Viruses 2021;13:104. 10.3390/v1301010433451106PMC7828589
Pervolaraki K, Stanifer ML, Münchau S, Renn LA, Albrecht D, Kurzhals S, et al. Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut. Front Immunol 2017;8:459. 10.3389/fimmu.2017.0045928484457PMC5399069
  • Publisher :The Korean Society for Microbiology and The Korean Society of Virology
  • Publisher(Ko) :대한미생물학회‧대한바이러스학회
  • Volume : 53
  • No :1
  • Pages :51-60
  • Received Date : 2023-04-01
  • Revised Date : 2023-06-09
  • Accepted Date : 2023-06-12